ICU acquired weakness or something else?
Keywords:
Critical illness polyneuropathy, myopathy, ICU acquired weakness, ToxoplasmosisAbstract
An elderly female presented to ICU with generalized weakness and altered sensorium with significant past history of adenocarcinoma of larynx. She was managed with Radiation Therapy and Chemotherapy in the past but at present she developed aspiration pneumonitis and got intubated and was admitted to ICU. She then progressively developed muscle weakness, which was provisionally diagnosed and managed as critical illness polyneuromyopathy (ICU acquired weakness) and muscle biopsy was sent, as she did not show signs of neurological cause and recovery from her muscle weakness. She then developed Catheter related sepsis and septic shock, which was refractory, and then she passed away. Her muscle biopsy report, which was available postmortem, revealed that she had severe toxoplasma infestation, which was in shadow.
References
2. de Letter MA, Schmitz PI, Visser LH, Verheul FA, Schellens RL, Op de Coul DA, et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001;29:2281-6.
3. De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002;288:2859-67.
4. Bolton CF. Evidence of neuromuscular dysfunction in the early stages of the systemic inflammatory response syndrome. Intensive Care Med 2000;26:1179-80.
5. Bednarik J, Vondracek P, Dusek L, Moravcova E, Cundrle I. Risk factors for critical illness polyneuromyopathy. J Neurol 2005;252:343-51.
6. Garnacho-Montero J1, Madrazo-Osuna J, Garcia-Garmendia JL, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar A, Garnacho-Montero MC, Moyano-Del-Estad MR. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001;27:1288-96.
7. Friedrich O, Fink RH, Hund E. Understanding critical illness myopathy: approaching the pathomechanism. J Nutr 2005;135:1813-17.
8. Schweickert WD, Hall J. ICU-Acquired Weakness. Chest 2007;131:1541-9.
9. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996;24:1408-16.
10. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000;30:1217-58.
11. Rai SK, Matsumura T, Ono K, Abe A, Hirai K, Rai G, et al. High Toxoplasma seroprevalence associated with meat eating habits of locals in Nepal. Asia Pac J Public Health 1999;11:89-93.
12. Cook AJ, Gilbert RE, Buffolano W, Zufferey J, Petersen E, Jenum PA, et al. Sources of Toxoplasma infection in pregnant women: European multicenter case-control study. European Research Network on Congenital Toxoplasmosis. BMJ 2000;321:142-7.
13. Leal FE, Cavazzana CL, de Andrade HF Jr, Galisteo A Jr, de Mendonca JS, Kallas EG. Toxoplasma gondi pneumonia in immunocompetent subjects: case report and review. Clin Infect Dis 2007;44:62-6.
14. Montoya JG, Jordan R, Lingamneni S, Berry GJ, Remington JS. Toxoplasmic myocarditis and polymyositis in patients with acquired toxoplasmosis diagnosed during life. Clin Infect Dis 1997;24:676-83.
15. Behan WM, Behan PO, Draper IT, Williams H. Does Toxoplasma cause polymyositis? Report of a case of polymyositis associated with toxoplasmosis and a critical review of the literature. Acta Neuropathol 1983;61:246-52.
Downloads
Published
How to Cite
Issue
Section
License
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
